These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25736784)

  • 1. MiRNAs in primary cutaneous lymphomas.
    Yu X; Li Z; Liu J
    Cell Prolif; 2015 Jun; 48(3):271-7. PubMed ID: 25736784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of microRNAs in lung cancer progression.
    Zhang WC; Liu J; Xu X; Wang G
    Med Oncol; 2013; 30(3):675. PubMed ID: 23925663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of miRNAs in cutaneous squamous cell carcinoma.
    Yu X; Li Z
    J Cell Mol Med; 2016 Jan; 20(1):3-9. PubMed ID: 26508273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNAs as Key Players in the Management of Cutaneous Melanoma.
    Lorusso C; De Summa S; Pinto R; Danza K; Tommasi S
    Cells; 2020 Feb; 9(2):. PubMed ID: 32054078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
    Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
    J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LymphomiRs: microRNAs with regulatory roles in lymphomas.
    Kozloski GA; Lossos IS
    Curr Opin Hematol; 2015 Jul; 22(4):362-8. PubMed ID: 26049758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microRNAs in melanoma.
    Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
    Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis.
    Huang T; Zhou Y; Zhang J; Wong CC; Li W; Kwan JSH; Yang R; Chan AKY; Dong Y; Wu F; Zhang B; Cheung AHK; Wu WKK; Cheng ASL; Yu J; Wong N; Kang W; To KF
    Oncogene; 2018 Mar; 37(9):1159-1174. PubMed ID: 29234151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
    Wang K; Chen M; Wu W
    World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in the thyroid.
    Boufraqech M; Klubo-Gwiezdzinska J; Kebebew E
    Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):603-619. PubMed ID: 27923454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA profiling identifies deregulated miRNAs associated with osteosarcoma development and time to metastasis in two large cohorts.
    Andersen GB; Knudsen A; Hager H; Hansen LL; Tost J
    Mol Oncol; 2018 Jan; 12(1):114-131. PubMed ID: 29120535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
    Leibowitz-Amit R; Sidi Y; Avni D
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.
    García-Sancha N; Corchado-Cobos R; Pérez-Losada J; Cañueto J
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome.
    Petriella D; De Summa S; Lacalamita R; Galetta D; Catino A; Logroscino AF; Palumbo O; Carella M; Zito FA; Simone G; Tommasi S
    Tumour Biol; 2016 Apr; 37(4):5503-13. PubMed ID: 26566629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of miRNAs-cMYC circuits is a key event in refractory celiac disease type-2 lymphomagenesis.
    Vaira V; Gaudioso G; Laginestra MA; Terrasi A; Agostinelli C; Bosari S; Di Sabatino A; Vanoli A; Paulli M; Ferrero S; Roncoroni L; Lombardo V; Perera LP; Fabris S; Vecchi M; Pileri S; Elli L
    Clin Sci (Lond); 2020 May; 134(10):1151-1166. PubMed ID: 32420596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intricate role of miR-155 in carcinogenesis: potential implications for esophageal cancer research.
    Nariman-Saleh-Fam Z; Saadatian Z; Daraei A; Mansoori Y; Bastami M; Tavakkoli-Bazzaz J
    Biomark Med; 2019 Feb; 13(2):147-159. PubMed ID: 30672305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNAs in B-cell lymphoma: Molecular mechanisms and biomarker potential.
    Solé C; Larrea E; Di Pinto G; Tellaetxe M; Lawrie CH
    Cancer Lett; 2017 Oct; 405():79-89. PubMed ID: 28757417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA in Malignant Lymphoma.
    Tagawa H
    Adv Exp Med Biol; 2015; 889():41-50. PubMed ID: 26658995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microRNAs in lymphoid biology and disease.
    Fabbri M; Croce CM
    Curr Opin Hematol; 2011 Jul; 18(4):266-72. PubMed ID: 21519241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.